Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets

B Wang, L Wu, J Chen, L Dong, C Chen… - Signal transduction and …, 2021 - nature.com
The arachidonic acid (AA) pathway plays a key role in cardiovascular biology,
carcinogenesis, and many inflammatory diseases, such as asthma, arthritis, etc. Esterified …

Arachidonic acid metabolites in cardiovascular and metabolic diseases

T Sonnweber, A Pizzini, M Nairz, G Weiss… - International journal of …, 2018 - mdpi.com
Lipid and immune pathways are crucial in the pathophysiology of metabolic and
cardiovascular disease. Arachidonic acid (AA) and its derivatives link nutrient metabolism to …

Arachidonic acid metabolism in health and disease

Y Zhang, Y Liu, J Sun, W Zhang, Z Guo, Q Ma - MedComm, 2023 - Wiley Online Library
Arachidonic acid (AA), an n‐6 essential fatty acid, is a major component of mammalian cells
and can be released by phospholipase A2. Accumulating evidence indicates that AA plays …

Leukotriene receptors as potential therapeutic targets

T Yokomizo, M Nakamura… - The Journal of clinical …, 2018 - Am Soc Clin Investig
Leukotrienes, a class of arachidonic acid–derived bioactive molecules, are known as
mediators of allergic and inflammatory reactions and considered to be important drug …

Montelukast and acute coronary syndrome: the endowed drug

BM Alomair, HM Al-Kuraishy, AI Al-Gareeb… - Pharmaceuticals, 2022 - mdpi.com
Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …

Analysis of neuropsychiatric diagnoses after montelukast initiation

T Paljarvi, J Forton, S Luciano, K Herttua… - JAMA network …, 2022 - jamanetwork.com
Importance The evidence base for the association between montelukast and adverse
neuropsychiatric outcomes is mixed and inconclusive. Several methodological limitations …

Role of the cysteinyl leukotrienes in the pathogenesis and progression of cardiovascular diseases

F Colazzo, P Gelosa, E Tremoli, L Sironi… - Mediators of …, 2017 - Wiley Online Library
Cysteinyl leukotrienes (CysLTs) are potent lipid inflammatory mediators synthesized from
arachidonic acid, through the 5‐lipoxygenase (5‐LO) pathway. Owing to their properties …

Sex differences in eicosanoid formation and metabolism: a possible mediator of sex discrepancies in cardiovascular diseases

SH Gerges, AOS El-Kadi - Pharmacology & therapeutics, 2022 - Elsevier
Arachidonic acid is metabolized by cyclooxygenase, lipoxygenase, and cytochrome P450
enzymes to produce prostaglandins, leukotrienes, epoxyeicosatrienoic acids (EETs), and …

Classes of lipid mediators and their effects on vascular inflammation in atherosclerosis

V Lubrano, R Ndreu, S Balzan - International Journal of Molecular …, 2023 - mdpi.com
It is commonly believed that the inactivation of inflammation is mainly due to the decay or
cessation of inducers. In reality, in connection with the development of atherosclerosis …

Two-pronged approach to anti-inflammatory therapy through the modulation of the arachidonic acid cascade

A Sala, E Proschak, D Steinhilber, GE Rovati - Biochemical Pharmacology, 2018 - Elsevier
Chronic inflammation and pain is a major global health problem, and nonsteroidal anti-
inflammatory drugs (NSAIDs) remain the most frequently prescribed drugs and common …